{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 1.2213655710220337, "B": 0.9663017392158508, "C": 1.3200743198394775, "D": 3.6193761825561523, "E": 2.042999029159546}, "ranked_options": [{"letter": "B", "text": "Rituximab", "avg_nll": 0.9663017392158508}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 1.2213655710220337}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 1.3200743198394775}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 2.042999029159546}, {"letter": "D", "text": "Vincristine", "avg_nll": 3.6193761825561523}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 3.2592380046844482, "B": 1.3419780731201172, "C": 2.194611072540283, "D": 2.3250908851623535, "E": 2.5097272396087646}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 1.3419780731201172}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 2.194611072540283}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 2.3250908851623535}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 2.5097272396087646}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 3.2592380046844482}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 2.3219361305236816, "B": 5.0882415771484375, "C": 9.430728912353516, "D": 5.744071006774902, "E": 2.7583425045013428}, "ranked_options": [{"letter": "A", "text": "Multiple sclerosis", "avg_nll": 2.3219361305236816}, {"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 2.7583425045013428}, {"letter": "B", "text": "Dementia", "avg_nll": 5.0882415771484375}, {"letter": "D", "text": "Brain abscess", "avg_nll": 5.744071006774902}, {"letter": "C", "text": "Parkinson", "avg_nll": 9.430728912353516}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 1.8198212385177612, "B": 1.8969649076461792, "C": 1.9313081502914429, "D": 2.5019173622131348, "E": 2.304823160171509}, "ranked_options": [{"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 1.8198212385177612}, {"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.8969649076461792}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 1.9313081502914429}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 2.304823160171509}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.5019173622131348}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 5.517298221588135, "B": 5.862163543701172, "C": 4.837813377380371, "D": 1.6610416173934937, "E": 5.3949432373046875}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 1.6610416173934937}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 4.837813377380371}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 5.3949432373046875}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 5.517298221588135}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 5.862163543701172}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 2.797821521759033, "B": 2.8072993755340576, "C": 1.459625244140625, "D": 1.5430068969726562, "E": 2.411980628967285}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 1.459625244140625}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 1.5430068969726562}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 2.411980628967285}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 2.797821521759033}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 2.8072993755340576}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 3.7994518280029297, "B": 3.4229676723480225, "C": 1.8077586889266968, "D": 2.823061466217041, "E": 3.727154016494751}, "ranked_options": [{"letter": "C", "text": "Optiray 320", "avg_nll": 1.8077586889266968}, {"letter": "D", "text": "Gadovist", "avg_nll": 2.823061466217041}, {"letter": "B", "text": "Imeron 400", "avg_nll": 3.4229676723480225}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 3.727154016494751}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 3.7994518280029297}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 2.3989994525909424, "B": 1.67071533203125, "C": 2.360745906829834, "D": 2.5059094429016113, "E": 2.344316005706787}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 1.67071533203125}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 2.344316005706787}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 2.360745906829834}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 2.3989994525909424}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 2.5059094429016113}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 1.5694465637207031, "B": 2.673893928527832, "C": 1.1355669498443604, "D": 2.6875293254852295, "E": 2.4119551181793213}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 1.1355669498443604}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 1.5694465637207031}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 2.4119551181793213}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.673893928527832}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.6875293254852295}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 2.025669813156128, "B": 2.104835033416748, "C": 2.4707298278808594, "D": 1.9734504222869873, "E": 2.6576719284057617}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 1.9734504222869873}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 2.025669813156128}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 2.104835033416748}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 2.4707298278808594}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 2.6576719284057617}], "correct_answer_letter": "B", "error": null, "method": "local"}
